润都股份：氢氯噻嗪获化学原料药上市申请批准

Group 1 - The company, Rundu Co., Ltd. (002923.SZ), has received approval from the National Medical Products Administration for the listing application of hydrochlorothiazide as a chemical raw material drug [1] - Hydrochlorothiazide is indicated for the treatment of edema, hypertension, central or renal diabetes insipidus, and nephrolithiasis [1]